Combination of biomarkers for diagnosis of acute kidney injury after cardiopulmonary bypass
John Richard Prowle, Paolo Calzavacca, Elisa Licari, E Valentina Ligabo, Jorge E Echeverri, Sean M Bagshaw, Anja Haase-Fielitz, Michael Haase, Vaughn Ostland, Eisei Noiri, Mark Westerman, Prasad Devarajan, Rinaldo Bellomo
Renal Failure | TAYLOR & FRANCIS LTD | Published : 2015
This study has been supported by Austin Health ICU Research Fund. Dr MW is a shareholder, President and CEO of Intrinsic LifeSciences, developer and distributor of an ELISA assay for hepcidin. Dr VA is a shareholder and officer of Intrinsic LifeSciences. Dr JRP and Professor RB are named in a US patent in conjunction with Dr MW and Prof PD is a co-inventor on NGAL patents for the diagnosis of acute kidney injury. SB, PD, JP and RB have received consulting/speaking fees from Alere Inc. RB has received consulting fees from Abbot Diagnostics Inc. JRP is responsible for statistical design and analysis.